Uncategorized | Lablytica
David Pekar becomes CEO at Lablytica

David Pekar becomes CEO at Lablytica

Lablytica Life Science AB started in November 2019 when Recipharm’s GLP bioanalysis business was divested to Center for Translational Research AB (CTR). David Pekar has since then been the Site Manager and Chief Scientific Officer at Lablytica. As announced by CTR,...